Drug Trial Radar · NCT06385795
A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause
Last checked: Nov 19, 2026Latest source record: Sep 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Apr 22, 2024
Primary completion
Aug 13, 2025
Study completion Aug 13, 2025
Sponsor
- Lead sponsor
- Noema Pharma AGIndustry
- Sponsor type
- Industry
- First posted
- Apr 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 45 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the safety, tolerability, and preliminary effectiveness of NOE-115 on moderate to severe vasomotor symptoms (hot flashes) due to menopause in women.
Conditions
- Menopause Syndrome
- Menopause
- Hot Flashes
Interventions
NOE-115Drug
NOE-115 is an investigational monoamine modulator which has potential anti-inflammatory activity.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Withdrawals Due to Adverse Events While on NOE-115 for Any ReasonTime frame: 4 weeks
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Noema PMM-201 Site #104
San Diego, California
Noema PMM-201 Site #102
Jacksonville, Florida
Noema PMM-201 Site #101
Atlanta, Georgia
Noema PMM-201 Site #106
Las Vegas, Nevada
Noema PMM-201 Site #103
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.